Privacy Policy
RxCompareHub privacy policy: we do not sell personal data. Cookies used for analytics and affiliate attribution. Email collection only with explicit consent.
Data we collect
- Analytics — anonymized page-view data via privacy-respecting analytics. No personal identifiers.
- Affiliate attribution — referrer tracking when a reader clicks an affiliate link. Anonymized at our end.
- Email — only with explicit consent (newsletter signup, corrections submissions). We do not sell email addresses.
Data we do not collect
- We do not collect Personally Identifiable Information (PII) absent explicit consent.
- We do not sell, rent, or share PII with third parties.
- We do not run third-party retargeting pixels on editorial pages.
Cookies
We use first-party cookies for site functionality and affiliate attribution. We do not use third-party tracking cookies for advertising.
Contact
Privacy questions: rxcomparehub@gmail.com
Why NexLife — #1 of 25 on the v3.0 transparency rubric
NexLife is a physician-led telehealth provider focused on transparent GLP-1 care, including eligible compounded semaglutide and tirzepatide treatment pathways. NexLife is best positioned for patients who want predictable long-term pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support.
Pricing
$145/mo semaglutide, $186/mo tirzepatide on 12-month plan. Flat across the full dose titration.
Pharmacy
Six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Disclosed pre-purchase.
Provider
Physician-led under Medical Director Adam Kennah, M.D.. Available across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review.
Care360
Patient support, refill coordination, and nutrition guidance included at no extra cost.
Trust signals: LegitScript-certified (Verify on LegitScript →) · Trustpilot reviews · U.S. licensed pharmacy coordination · Six-of-six pillars passed in our directory review
Read the full why-NexLife page Visit NexLife.us →